The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Feline Vaccines Market Research Report 2024
Synopsis
Feline vaccinations stimulate your kitten or cat's immune system in order to create protection from specific infectious diseases. This can cause mild symptoms to occur ranging from soreness at the injection site to fever and allergic reactions.
Global Feline Vaccines market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Feline Vaccines market research.
Key manufacturers engaged in the Feline Vaccines industry include Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer), Elanco Animal Health, Virbac and Kyoto Biken Laboratories, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Feline Vaccines were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Feline Vaccines market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Feline Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck & Co
Boehringer Ingelheim International
Zoetis (Pfizer)
Elanco Animal Health
Virbac
Kyoto Biken Laboratories
Segment by Type
F3 (FVRCP) Vaccination
Feline Leukaemia Vaccination
Rabies Vaccination
Heartworm Vaccination
Others
Segment by Application
Prevention of Feline Panleukopaenia
Prevention of Feline Rhinotracheitis
Prevention of Feline Calicivirus
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Feline Vaccines report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Feline vaccinations stimulate your kitten or cat's immune system in order to create protection from specific infectious diseases. This can cause mild symptoms to occur ranging from soreness at the injection site to fever and allergic reactions.
Global Feline Vaccines market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Feline Vaccines market research.
Key manufacturers engaged in the Feline Vaccines industry include Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer), Elanco Animal Health, Virbac and Kyoto Biken Laboratories, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Feline Vaccines were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Feline Vaccines market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Feline Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck & Co
Boehringer Ingelheim International
Zoetis (Pfizer)
Elanco Animal Health
Virbac
Kyoto Biken Laboratories
Segment by Type
F3 (FVRCP) Vaccination
Feline Leukaemia Vaccination
Rabies Vaccination
Heartworm Vaccination
Others
Segment by Application
Prevention of Feline Panleukopaenia
Prevention of Feline Rhinotracheitis
Prevention of Feline Calicivirus
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Feline Vaccines report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Feline Vaccines Market Overview
1.1 Product Overview and Scope of Feline Vaccines
1.2 Feline Vaccines Segment by Type
1.2.1 Global Feline Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 F3 (FVRCP) Vaccination
1.2.3 Feline Leukaemia Vaccination
1.2.4 Rabies Vaccination
1.2.5 Heartworm Vaccination
1.2.6 Others
1.3 Feline Vaccines Segment by Application
1.3.1 Global Feline Vaccines Market Value by Application: (2023-2029)
1.3.2 Prevention of Feline Panleukopaenia
1.3.3 Prevention of Feline Rhinotracheitis
1.3.4 Prevention of Feline Calicivirus
1.3.5 Others
1.4 Global Feline Vaccines Market Size Estimates and Forecasts
1.4.1 Global Feline Vaccines Revenue 2018-2029
1.4.2 Global Feline Vaccines Sales 2018-2029
1.4.3 Global Feline Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Feline Vaccines Market Competition by Manufacturers
2.1 Global Feline Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Feline Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Feline Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Feline Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Feline Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Feline Vaccines, Product Type & Application
2.7 Feline Vaccines Market Competitive Situation and Trends
2.7.1 Feline Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Feline Vaccines Players Market Share by Revenue
2.7.3 Global Feline Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Feline Vaccines Retrospective Market Scenario by Region
3.1 Global Feline Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Feline Vaccines Global Feline Vaccines Sales by Region: 2018-2029
3.2.1 Global Feline Vaccines Sales by Region: 2018-2023
3.2.2 Global Feline Vaccines Sales by Region: 2024-2029
3.3 Global Feline Vaccines Global Feline Vaccines Revenue by Region: 2018-2029
3.3.1 Global Feline Vaccines Revenue by Region: 2018-2023
3.3.2 Global Feline Vaccines Revenue by Region: 2024-2029
3.4 North America Feline Vaccines Market Facts & Figures by Country
3.4.1 North America Feline Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Feline Vaccines Sales by Country (2018-2029)
3.4.3 North America Feline Vaccines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Feline Vaccines Market Facts & Figures by Country
3.5.1 Europe Feline Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Feline Vaccines Sales by Country (2018-2029)
3.5.3 Europe Feline Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Feline Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Feline Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Feline Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Feline Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Feline Vaccines Market Facts & Figures by Country
3.7.1 Latin America Feline Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Feline Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Feline Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Feline Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Feline Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Feline Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Feline Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Feline Vaccines Sales by Type (2018-2029)
4.1.1 Global Feline Vaccines Sales by Type (2018-2023)
4.1.2 Global Feline Vaccines Sales by Type (2024-2029)
4.1.3 Global Feline Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Feline Vaccines Revenue by Type (2018-2029)
4.2.1 Global Feline Vaccines Revenue by Type (2018-2023)
4.2.2 Global Feline Vaccines Revenue by Type (2024-2029)
4.2.3 Global Feline Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Feline Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Feline Vaccines Sales by Application (2018-2029)
5.1.1 Global Feline Vaccines Sales by Application (2018-2023)
5.1.2 Global Feline Vaccines Sales by Application (2024-2029)
5.1.3 Global Feline Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Feline Vaccines Revenue by Application (2018-2029)
5.2.1 Global Feline Vaccines Revenue by Application (2018-2023)
5.2.2 Global Feline Vaccines Revenue by Application (2024-2029)
5.2.3 Global Feline Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Feline Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck & Co
6.1.1 Merck & Co Corporation Information
6.1.2 Merck & Co Description and Business Overview
6.1.3 Merck & Co Feline Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck & Co Feline Vaccines Product Portfolio
6.1.5 Merck & Co Recent Developments/Updates
6.2 Boehringer Ingelheim International
6.2.1 Boehringer Ingelheim International Corporation Information
6.2.2 Boehringer Ingelheim International Description and Business Overview
6.2.3 Boehringer Ingelheim International Feline Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim International Feline Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim International Recent Developments/Updates
6.3 Zoetis (Pfizer)
6.3.1 Zoetis (Pfizer) Corporation Information
6.3.2 Zoetis (Pfizer) Description and Business Overview
6.3.3 Zoetis (Pfizer) Feline Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Zoetis (Pfizer) Feline Vaccines Product Portfolio
6.3.5 Zoetis (Pfizer) Recent Developments/Updates
6.4 Elanco Animal Health
6.4.1 Elanco Animal Health Corporation Information
6.4.2 Elanco Animal Health Description and Business Overview
6.4.3 Elanco Animal Health Feline Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Elanco Animal Health Feline Vaccines Product Portfolio
6.4.5 Elanco Animal Health Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Feline Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Virbac Feline Vaccines Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Kyoto Biken Laboratories
6.6.1 Kyoto Biken Laboratories Corporation Information
6.6.2 Kyoto Biken Laboratories Description and Business Overview
6.6.3 Kyoto Biken Laboratories Feline Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Kyoto Biken Laboratories Feline Vaccines Product Portfolio
6.6.5 Kyoto Biken Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Feline Vaccines Industry Chain Analysis
7.2 Feline Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Feline Vaccines Production Mode & Process
7.4 Feline Vaccines Sales and Marketing
7.4.1 Feline Vaccines Sales Channels
7.4.2 Feline Vaccines Distributors
7.5 Feline Vaccines Customers
8 Feline Vaccines Market Dynamics
8.1 Feline Vaccines Industry Trends
8.2 Feline Vaccines Market Drivers
8.3 Feline Vaccines Market Challenges
8.4 Feline Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
